Skip to main navigation Skip to search Skip to main content

HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion Proteins

  • Dennis L. Buckley
  • , Kanak Raina
  • , Nicole Darricarrere
  • , John Hines
  • , Jeffrey L. Gustafson
  • , Ian E. Smith
  • , Afjal H. Miah
  • , John D. Harling
  • , Craig M. Crews
  • Yale University
  • Dana-Farber Cancer Institute
  • GlaxoSmithKline

Research output: Contribution to journalArticlepeer-review

413 Scopus citations

Abstract

Small molecule-induced protein degradation is an attractive strategy for the development of chemical probes. One method for inducing targeted protein degradation involves the use of PROTACs, heterobifunctional molecules that can recruit specific E3 ligases to a desired protein of interest. PROTACs have been successfully used to degrade numerous proteins in cells, but the peptidic E3 ligase ligands used in previous PROTACs have hindered their development into more mature chemical probes or therapeutics. We report the design of a novel class of PROTACs that incorporate small molecule VHL ligands to successfully degrade HaloTag7 fusion proteins. These HaloPROTACs will inspire the development of future PROTACs with more drug-like properties. Additionally, these HaloPROTACs are useful chemical genetic tools, due to their ability to chemically knock down widely used HaloTag7 fusion proteins in a general fashion.

Original languageEnglish
Pages (from-to)1831-1837
Number of pages7
JournalACS Chemical Biology
Volume10
Issue number8
DOIs
StatePublished - Aug 21 2015

Fingerprint

Dive into the research topics of 'HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion Proteins'. Together they form a unique fingerprint.

Cite this